ImmunityBio (26CA.XETRA) Q3 2026 Earnings

12AugConfirmed
Q2 2026
Next
-0.53
-0.37
-0.22
-0.06

Details

Expected EPS
-0.07572269124
Actual EPS
N/A
Surprise EPS
0.08
Surprise Percent
+100%

Description

ImmunityBio (26CA.XETRA) will report earnings of for Q3 2026 on August 12, 2026.

0 Comments

Share your thoughts